Johnson and johnson stock forecast.

Jul 20, 2023 · J&J is now forecasting full-year sales of $98.80 billion to $99.80 billion, about $1 billion higher than the guidance provided in April. The company raised its 2023 adjusted earnings outlook to ...

Johnson and johnson stock forecast. Things To Know About Johnson and johnson stock forecast.

Q1 2024 EPS Estimate Trends. Current. $2.63. 1 Month Ago. $2.63. 3 Months Ago. $2.75. Johnson & Johnson analyst estimates, including JNJ earnings per share estimates and analyst recommendations.In a 2011 video interview with FRONTLINE, Magic Johnson stated he had contracted HIV from unprotected sex.20‏/10‏/2023 ... The average price target for JNJ is $179.647 and analyst's rate the stock as a Buy. Overall Score - 3.8. Wall Street analysts are rating JNJ a ...

Johnson & Johnson’s revenue growth of 16% to $95 billion over the last twelve months, compared to $82 billion in 2019, 2. a 1.5% fall in its total shares outstanding to 2.6 billion, partly ...

The average 12-month JNJ stock price target was $187.40 with a 10.13% upside potential, above the all-time high of $179.47 seen on 17 August 2021. In a positive scenario, analysts forecast the JNJ share price could reach $200, while it could also fall to $161 in a negative scenario.

Nov 22, 2023 · In the last 12 months, JNJ had revenue of $95.33 billion and earned $34.62 billion in profits. Earnings per share was $13.46. Revenue. 95.33B. Gross Profit. 64.36B. Operating Income. 24.02B. Pretax Income. Q1 2024 EPS Estimate Trends. Current. $2.63. 1 Month Ago. $2.63. 3 Months Ago. $2.75. Johnson & Johnson analyst estimates, including JNJ earnings per share estimates and analyst recommendations.17‏/10‏/2023 ... SEANA SMITH: Johnson and Johnson shares on the move after beating the street's expectations. They also raised their 2023 revenue outlook. But ...Dec 1, 2023 · JNJ Earnings Date and Information. Johnson & Johnson last announced its quarterly earnings data on October 17th, 2023. The reported $2.66 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.52 by $0.14. The business had revenue of $21.35 billion for the quarter, compared to analysts' expectations of $21 billion.

Feb 4, 2022 · Johnson & Johnson's shares did reasonably well post-results announcement. JNJ's share price increased by +6.0% from $162.97 as of January 24, 2022 to $172.77 as of February 2, 2022. The company's ...

Johnson & Johnson (NYSE:JNJ) stock price online, charts, stock price history, technical and fundamental analysis, reports, dividends, comments and more. Simple and lightweight Johnson & Johnson Stock Live Chart is a powerful free tool that allows you to easily conduct technical analysis online without downloading additional files and applications.

JNJ (JNJ) reported Q3 2023 earnings per share (EPS) of $1.98, missing estimates of $2.52 by 21.38%. In the same quarter last year, JNJ's earnings per share (EPS) ...Johnson & Johnson is currently trading at a decade-low forward P/E ratio.This is particularly interesting since the healthcare behemoth rarely trades at a discount. With the company boasting six decades of consecutive annual dividend increases and the stock featuring a multi-year high yield following its recent decline, the buying opportunity many dividend growth investors have been waiting ...For JOHNSON & JOHNSON stock forecast for 2031, 12 predictions are offered for each month of 2031 with average JOHNSON & JOHNSON stock forecast of $636.67, a high forecast of $638.11, and a low forecast of $633.84. The average JOHNSON & JOHNSON stock forecast 2031 represents a 318.56% increase from the last price of $152.110000610352.Johnson & Johnson on Tuesday cautioned investors over the lingering impact of inflation-driven costs this year as the healthcare conglomerate issued a conservative full-year profit forecast, and ...JNJ - Johnson & Johnson - Stock screener for investors and traders, financial visualizations.Jul 15, 2021 · JNJ Stock Forecast. For 2021, analysts expect JNJ to earn $9.55 per share, and for 2022, analysts expect $10.42 in earnings. JNJ trades for a little under $170 as of my writing this, so your ... JNJ - Johnson & Johnson - Stock screener for investors and traders, financial visualizations.

10 stocks we like better than Johnson & Johnson When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool ...WebJohnson & Johnson. Market Cap. $372B. Today's Change. Current Price. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a ...Johnson & Johnson Stock Price Forecast, "JNJ" Predictons for2025Here’s what J&J reported for the third quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG, formerly known as Refinitiv: Earnings per share: $2.66 ...While ratings are subjective and will change, the latest Johnson & Johnson ( JNJ) rating was a reiterated with a price target of $0.00 to $215.00. The current price Johnson & Johnson ( JNJ) is ... The above table shows the analyst JNJ forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$154.66Johnson Pharma Share Price: Find the latest news on Johnson Pharma Stock Price. Get all the information on Johnson Pharma with historic price charts for NSE / BSE. ... Forecasts, Analysts ...

The all-time high Johnson & Johnson stock closing price was 177.11 on April 25, 2022. The Johnson & Johnson 52-week high stock price is 181.04, which is 14.3% ...Shares of healthcare giant Johnson & Johnson (JNJ 0.92%) are down more than 13% this year even as the S&P 500 is up 4%. In fact, the stock is trading only a bit higher than its 52-week low.

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9% ...Johnson Johnson Simple Exponential Smoothing . Analysis of Johnson Johnson Simple Exponential Smoothing, Johnson Johnson simple exponential smoothing forecast is a very popular model used to produce a smoothed price series. W...WebView live Johnson & Johnson chart to track its stock's price action. Find market predictions, JNJ financials and market news. ... News Ideas Financials Technicals …Oct 26, 2023 · Price Prediction forecast forJohnson & Johnson to October 27, and an in-depth analysis for the week of 22 October to 28 October. Monthly forecasts JNJ for 2023 with target levels, support & resistance insights to make informed investment decisions. Jan 25, 2022 · Johnson & Johnson Appoints Senior Leaders to Executive Committee (press release) Johnson & Johnson announces significant progress towards its climate goals – 100% renewable electricity for all sites in the United States, Canada and Europe by 2023 (press release) Johnson & Johnson Medical Devices Companies Announces Strategic Partnership with Apr 25, 2023 · Johnson & Johnson ( JNJ -0.21%) is one of the top healthcare companies in the world. But the company's legal problems, particularly with its talc products, weighed down its financials over the ... Unlock the potential of Johnson & Johnson (JNJ) with our insightful stock forecast. Explore the company's diverse portfolio of healthcare solutions and its commitment to improving the well-being of individuals worldwide. Stay ahead of the curve with our analysis of JNJ's research and development efforts, strategic acquisitions, and …Johnson & Johnson stock is now forming a flat base with a buy point at 183.45, ... 10/17/2023 Johnson & Johnson beat third-quarter forecasts Tuesday and raised its outlook for the year. JNJ stock ...

Johnson & Johnson is expected to post earnings of $2.62 per share for the current quarter, representing a year-over-year change of +1.2%. Over the last 30 days, the Zacks Consensus Estimate has ...

Johnson & Johnson Forecast, Short-Term " JNJ" Stock Price Prognosis for Next Days Walletinvestor.com JNJ Forecast, Long-Term Price Predictions for Next Months and Year: 2023, 2024Web

Read Full Company Summary for JNJ here. View Johnson & Johnson JNJ investment & stock information. Get the latest Johnson & Johnson JNJ detailed stock quotes, stock data, Real-Time ECN, charts ...Johnson & Johnson’s revenue growth of 16% to $95 billion over the last twelve months, compared to $82 billion in 2019, 2. a 1.5% fall in its total shares outstanding to 2.6 billion, partly ...Nov 30, 2023 · Analyst Future Growth Forecasts. Earnings vs Savings Rate: JNJ's forecast earnings growth (10.3% per year) is above the savings rate (2.2%). Earnings vs Market: JNJ's earnings (10.3% per year) are forecast to grow slower than the US market (14.7% per year). High Growth Earnings: JNJ's earnings are forecast to grow, but not significantly. Johnson & Johnson Stock: Outlook Amid Lawsuits. Aug. 15, 2023 8:45 AM ET Johnson & Johnson (JNJ) KVUE 38 Comments 23 Likes. Deep Value Ideas. 6.96K Followers. Follow. Summary.Get Johnson & Johnson (JNJ.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsHello Readers, We'll be Looking into JNJ STOCK FORECAST. Johnson & Johnson (J&J), a venerable name in the medical industry, stands as a beacon of. ... JNJ STOCK FORECAST | BEST PRICE PREDICTION 2024,2025-2030-2035-2040-2045-2050. by Sushant Pratap Singh November 13, 2023 November 13, 2023. Table of Contents.WebAug 11, 2023 · Kenvue is the consumer health company spun out of Johnson & Johnson. ... Kenvue stock currently trades for a forward price-to-earnings (P/E) ratio of 18 and a price-to-sales (P/S) ratio of 2.9. By ... Johnson & Johnson (JNJ) Company Description Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm.WebJun 30, 2021 · But slow, steady growth from a megacap stock can also achieve that mark. Johnson & Johnson (JNJ-0.20%) is already an enormous company. And its growth might not be exciting, but its consistency ...

Microsoft Corporation Common Stock. $352.60 -0.20 -0.06%. Find the latest dividend history for Johnson & Johnson Common Stock (JNJ) at Nasdaq.com.WebJohnson & Johnson annual free cash flow for 2022 was $17.728B, a 13.39% decline from 2021. Johnson & Johnson annual free cash flow for 2021 was $20.469B, a 0.12% decline from 2020. Johnson & Johnson annual free cash flow for 2020 was $20.494B, a 11.6% decline from 2019. Johnson & Johnson's biggest strength is its diversified business model.WebApril 11, 2023 — 08:45 am EDT. Johnson & Johnson stock (NYSE: JNJ) is scheduled to report its Q1 2023 results on Tuesday, April 18. We expect J&J to report revenues and earnings slightly above ...Instagram:https://instagram. rarest silver dollarprshxbond market forecast next 5 yearsbiggest prop trading firms It's worth noting that Johnson & Johnson, despite pulling its talc products in 2020, has won its share of the lawsuits -- including a 2021 decision that rejected a $50 million claim in Illinois ... regional banks stocksonline advertising courses 7 days ago Morningstar. Analyst Report: Kenvue Inc. Kenvue is the world’s largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Johnson & Johnson share forecasts, stock quote and buy / sell signals below. According to present data Johnson & Johnson's JNJ shares and potentially its market environment have been in bearish cycle last 12 months (if exists). bnym stock By achieving a more accurate demand forecast, Johnson & Johnson has improved its UFR, while consistently meeting inventory targets. The collaborative approach Demand planning and external manufacturing planning are both critical to the success of Johnson & Johnson and require a high level of process maturity and collaboration.WebJohnson & Johnson is expected to post earnings of $2.52 per share for the current quarter, representing a year-over-year change of -1.2%. Over the last 30 days, the Zacks Consensus Estimate has ...NYSE: JNJ ; $156.44 · $154.66 ; $157.72 · $155.47 ; $181.04 · $144.95 ...